SAFETY AND EFFICACY OF UPADACITINIB FOR PEDIATRIC PATIENTS WITH POLYARTICULAR COURSE JUVENILE IDIOPATHIC ARTHRITIS: AN INTERIM ANALYSIS OF AN OPEN-LABEL, PHASE 1 TRIAL

被引：4

作者：

Brunner, H. ^{[1
]}

Horneff, G. ^{[2
,3
]}

Foeldvari, I. ^{[4
]}

Anton, J. ^{[5
]}

Mohamed, M. E. ^{[6
]}

Qian, Y. ^{[6
]}

Unnebrink, K. ^{[7
]}

Hao, S. ^{[6
]}

Camp, H. ^{[6
]}

Khan, N. ^{[6
]}

Shmagel, A. ^{[6
]}

机构：

[1] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Rheumatol, Cincinnati, OH USA

[2] Asklepios Clin Sankt Augustin, Gen Pediat, St Augustin, Germany

[3] Univ Hosp Cologne, Paediat & Adolescents Med, Cologne, Germany

[4] Klinikum Eilbek, Hamburger Zentrum Kinder & Jugendrheumatol, Hamburg, Germany

[5] Univ Barcelona, Hosp Sant Joan Deu, Pediat Rheumatol, Barcelona, Spain

[6] AbbVie, Rheumatol, N Chicago, IL USA

[7] AbbVie Deutschland GmbH & Co KG, Rheumatol, Ludwigshafen, Germany

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷

关键词：

Clinical Trials; Safety; Outcome measures;

D O I：

10.1136/annrheumdis-2023-eular.3987

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：108 / 109

页数：2

共 50 条

[41] EFFICACY AND SAFETY OF TOCILIZUMAB IN POLYARTICULAR-COURSE JUVENILE IDIOPATHIC ARTHRITIS: 2 YEAR DATA FROM CHERISH
Baildam, Eileen
Ramanan, Athimalaipet
Woo, Patricia
Brunner, Hermine
Ruperto, Nicola
Zuber, Zbyszek
Cuttica, Ruben J.
Xavier, Ricardo
Penades, Inmaculada Calvo
Rubio-Perez, Nadina
Alexeeva, Ekaterina
Chasnyk, Vyacheslav
Chavez, Jose
Horneff, Gerd
Opoka-Winiarska, Violetta
Quartier, Pierre
Spindler, Alberto
Keane, Caroline
Bharucha, Kamal
Wang, Jianmei
Lovell, Daniel J.
Martini, Alberto
De Benedetti, Fabrizio
RHEUMATOLOGY, 2014, 53 : 52 - 53
[42] A Multi-Center, Open-Label Study to Assess the Pharmacokinetics, Efficacy and Safety of Certolizumab Pegol in Children and Adolescents with Moderately to Severely Active Polyarticular-Course Juvenile Idiopathic Arthritis: Week 24 Results
Brunner, Hermine I.
Ruperto, Nicolino
Keltsev, Vladimir
Alexeeva, Ekaterina
Abud-Mendoza, Carlos
Schmeling, Heinrike
Del Rocio Maldonado-Velazquez, Maria
Rubio-Perez, Nadina
Stanislav, Marina
Chasnyk, Vyacheslav
Brown, Diane
Henrickson, Michael
Kingsbury, Daniel
Rabinovich, C. Egla
Zeft, Andrew
Silverman, Earl
Wang, Maggie
Charlton, Philippa
Lledo-Garcia, Rocio
Shaughnessy, Laura
Lovell, Daniel J.
Martini, Alberto
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[43] Safety and Efficacy of Burosumab in Pediatric Patients With X-Linked Hypophosphatemia: A Phase 3/4 Open-Label Trial
Namba, Noriyuki
Kubota, Takuo
Muroya, Koji
Tanaka, Hiroyuki
Kanematsu, Masanori
Kojima, Masahiro
Orihara, Shunichiro
Kanda, Hironori
Seino, Yoshiki
Ozono, Keiichi
JOURNAL OF THE ENDOCRINE SOCIETY, 2022, 6 (05)
[44] LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA): 5-YEAR FOLLOW-UP OF AN OPEN-LABEL TRIAL
Ruperto, N.
Brunner, H. I.
Quartier, P.
Constantin, T.
Alexeeva, E.
Schneider, R.
Kone-Paut, I.
Schikler, K.
Marzan, K.
Wulffraat, N.
Padeh, S.
Chasnyk, V.
Wouters, C.
Kuemmerle-Deschner, J. B.
Kallinich, T.
Lauwerys, B.
Haddad, E.
Nasonov, E.
Trachana, M.
Vougiouka, O.
Leon, K.
Speziale, A.
Lheritier, K.
Martini, A.
Lovell, D.
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 265 - 266
[45] EFFICACY AND SAFETY OF SECUKINUMAB IN JUVENILE IDIOPATHIC ARTHRITIS: INTERIM RESULTS FROM THE EXTENSION OF THE JUNIPERA TRIAL
Ruperto, N.
Foeldvari, I.
Alexeeva, E.
Ayaz, N. Aktay
Schulert, G.
Ozen, S.
Popov, A.
Ramanan, A.
Scott, C.
Sozeri, B.
Zholobova, E.
Chakraborty, S.
Zhu, X.
Martin, R.
Whelan, S.
Kaur, S.
Pricop, L.
Lovell, D. J.
Martini, A.
Brunner, H.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 379 - 380
[46] 2.3 Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis (JRA): Findings from an open-label treatment extension
N Ruperto
DJ Lovell
R Cuttica
P Woo
G Espada
C Wouters
ED Silverman
Z Balogh
M Henrickson
J Davidson
I Foeldvari
L Imundo
G Simonini
J Oppermann
YK Shen
S Visvanathan
A Fasanmade
A Mendelsohn
A Martini
EH Giannini
Pediatric Rheumatology, 6 (Suppl 1)
[47] Efficacy and Safety of Secukinumab in Juvenile Idiopathic Arthritis: Interim Results from the Extension of the JUNIPERA Trial
Brunner, Hermine
Foeldvari, Ivan
Alexeeva, Ekaterina
Ayaz, Nuray Aktay
Schulert, Grant
Ozen, Seza
Popov, Artem
Ramanan, Athimalaipet V.
Scott, Christiaan
Sozeri, Betul
Zholobova, Elena
Chakraborty, Sudhanshu
Zhu, Xuan
Martin, Ruvie
Whelan, Sarah
Kaur, Sharonjeet
Pricop, Luminita
Lovell, Daniel J.
Martini, Alberto
Ruperto, Nicolino
ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 729 - 731
[48] Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial
Tynjala, Pirjo
Vahasalo, Paula
Tarkiainen, Maarit
Kroger, Liisa
Aalto, Kristiina
Malin, Merja
Putto-Laurila, Anne
Honkanen, Visa
Lahdenne, Pekka
ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (09) : 1605 - 1612
[49] Efficacy and Safety Of Tocilizumab In Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: 2-Year Data From Cherish.
Brunner, Hermine I.
Ruperto, Nicolino
Zuber, Zbigniew
Cuttica, Ruben J.
Xavier, Ricardo
Calvo, Inmaculada
Rubio, Nadina
Alekseeva, Ekaterina
Chasnyk, Vyacheslav
Chavez, Jose
Horneff, Gerd
Opoka-Winiarska, Violetta
Quartier, Pierre
Spindler, Alberto
Keane, Caroline
Bharucha, Kamal N.
Wang, Jianmei
Lovell, Daniel J.
Martini, Alberto
De Benedetti, Fabrizio
ARTHRITIS AND RHEUMATISM, 2013, 65 : S335 - S335
[50] SAFETY AND EFFICACY OF OPEN-LABEL DUPILUMAB IN ADULT PATIENTS WITH ATOPIC DERMATITIS: AN INTERIM ANALYSIS AT WEEK 76
Gebauer, Kurt
Rubel, Diana
Deleuran, Mette
Thaci, Diamant
Boguniewicz, Mark
Bissonnette, Robert
Chen, Zhen
Gadkari, Abhijit
Eckert, Laurent
Rossi, Ana B.
Ardeleanu, Marius
INTERNAL MEDICINE JOURNAL, 2019, 49 : 19 - 19

← 1 2 3 4 5 →